Osteoprotegerin (OPG) is a novel secreted member of the
tumor necrosis factor receptor family which plays a crucial role in negative regulation of osteoclastic
bone resorption. OPG-deficient (OPG-/-) mice develop severe
osteoporosis caused by significant enhancement of
bone resorption by osteoclasts. We investigated the effect of administering
bisphosphonate on mandibular growth and development in OPG-/- mice. Eight-week-old male OPG-/- mice and wild-type (WT) mice were administered
bisphosphonate (1.25 mg/kg
body weight) intraperitoneally once every 3 days for 30 days. All bone formation-related parameters and
bone resorption-related parameters were significantly lower in OPG-/- mice with
bisphosphonate than in those without
bisphosphonate. The volume of the whole condyle and the mandibular length in OPG-/- mice without
bisphosphonate were significantly smaller than in WT mice without
bisphosphonate.
Bisphosphonate treatment of the OPG-/- mice resulted in an increase in the volume of the mandibular condyle and mandibular ramus length. In fact, the mandibular ramus length in OPG-/- mice with
bisphosphonate was similar to the length in WT mice without
bisphosphonate. Histologically, the surface irregularity of the mandibular condyle that was observed in the OPG-/- mice without
bisphosphonate tended to be less marked in the OPG-/- mice with
bisphosphonate, and the proportion of the area of the cartilage layer relative to the whole condyle was significantly larger in OPG-/- mice with
bisphosphonate than in those without
bisphosphonate. In conclusion,
bisphosphonate treatment results in an increase in mandibular condylar dimensions and normalization of mandibular ramus growth.